The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Bifidenone ID: ALA4083202
PubChem CID: 126508539
Max Phase: Preclinical
Molecular Formula: C21H26O5
Molecular Weight: 358.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CC[C@H]1C[C@]2([C@@H](C)Cc3ccc(OC)c(OC)c3)OCOC2=CC1=O
Standard InChI: InChI=1S/C21H26O5/c1-5-6-16-12-21(20(11-17(16)22)25-13-26-21)14(2)9-15-7-8-18(23-3)19(10-15)24-4/h5,7-8,10-11,14,16H,1,6,9,12-13H2,2-4H3/t14-,16-,21+/m0/s1
Standard InChI Key: BHTLRQBVGVBCSE-WDUKFBBWSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
9.8930 -13.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8930 -13.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6024 -14.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3077 -13.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6024 -12.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3069 -13.1643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9159 -12.6202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5852 -11.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7719 -11.9574 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8847 -12.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8818 -11.5232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1743 -12.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4611 -12.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1817 -14.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4693 -13.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7581 -14.4071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6024 -15.2212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4611 -11.5280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7487 -11.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0373 -11.5332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0429 -12.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7559 -12.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3339 -12.7764 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3235 -11.1281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6192 -12.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3195 -10.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 5 1 0
2 3 1 0
3 4 1 0
4 6 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
5 9 1 6
5 10 1 0
10 11 1 6
10 12 1 0
12 13 1 0
2 14 1 1
14 15 1 0
15 16 2 0
3 17 2 0
13 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 13 1 0
21 23 1 0
20 24 1 0
23 25 1 0
24 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.43Molecular Weight (Monoisotopic): 358.1780AlogP: 3.67#Rotatable Bonds: 7Polar Surface Area: 53.99Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.84CX LogD: 3.84Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: 1.35
References 1. Williams RB, Martin SM, Lawrence JA, Norman VL, O'Neil-Johnson M, Eldridge GR, Starks CM.. (2017) Isolation and Identification of the Novel Tubulin Polymerization Inhibitor Bifidenone., 80 (3): [PMID:28335606 ] [10.1021/acs.jnatprod.6b00893 ] 2. Huang Z, Williams RB, Martin SM, Lawrence JA, Norman VL, O'Neil-Johnson M, Harding J, Mangette JE, Liu S, Guzzo PR, Starks CM, Eldridge GR.. (2018) Bifidenone: Structure-Activity Relationship and Advanced Preclinical Candidate., 61 (15): [PMID:29995409 ] [10.1021/acs.jmedchem.7b01644 ]